Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Healthy Adults × eltrombopag × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Sarcoma 2 Thrombocytopenia 1 Solid Tumor, Childhood 1 Osteosarcoma 1 Neoplasms, Connective and Soft Tissue 1 Leukemia, Myelomonocytic, Acute 1 Leukemia, Myeloid, Acute 1 Leukemia, Monocytic, Acute 1 Leukemia, Megakaryoblastic, Acute 1 Leukemia, Erythroblastic, Acute 1 Leukemia, Eosinophilic, Acute 1 Leukemia, Basophilic, Acute 1 Healthy Volunteers 1 Healthy Adults 1 Congenital Abnormalities 1 Bone Neoplasms 1

Interventions

eltrombopag 1 adagrasib 1 Peptides 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05924152 2024-03-13

A PK Study to Assess the Drug-drug Interaction of a BCRP Inhibitor on Adagrasib

Mirati Therapeutics Inc.

Phase 1 Completed

Healthy Adults

Data powered by HemOnc (CC BY 4.0) Colophon ⚡